Irritable Bowel Syndrome (IBS) Treatment Market Size

Irritable Bowel Syndrome Treatment Market size is estimated at USD 3.6 billion in 2024 and is estimated to reach USD 10.7 billion by the end of 2037, expanding at a CAGR of 8.8% during the forecast period, i.e., 2025-2037. In 2025, the industry size of irritable bowel syndrome treatment is evaluated at USD 3.9 billion.

The rise in sedentary lifestyles and poor eating habits are some of the major reasons boosting the prevalence rates of irritable bowel syndrome, which is subsequently driving high demand for IBS treatment solutions. For instance, the International Foundation for Gastrointestinal Disorders (IFFGD) estimates that around 5 % to 10% of the population around the globe are living with irritable bowel syndrome issues. Around 20% to 40% of visits to gastrointestinal clinics are due to irritable bowel syndrome issues.

The rising awareness programs and increasing research funding are leading to the development of advanced irritable bowel syndrome therapeutic drugs. Globally, April is commemorated as irritable bowel syndrome awareness month. Several hospitals and clinics run free diagnosis and awareness campaigns during this period. Such initiatives are set to fuel the irritable bowel syndrome treatment market growth in the coming years.